Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

983 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation.
Torres J, Chaparro M, Julsgaard M, Katsanos K, Zelinkova Z, Agrawal M, Ardizzone S, Campmans-Kuijpers M, Dragoni G, Ferrante M, Fiorino G, Flanagan E, Gomes CF, Hart A, Hedin CR, Juillerat P, Mulders A, Myrelid P, O'Toole A, Rivière P, Scharl M, Selinger CP, Sonnenberg E, Toruner M, Wieringa J, Van der Woude CJ. Torres J, et al. Among authors: ferrante m. J Crohns Colitis. 2023 Jan 27;17(1):1-27. doi: 10.1093/ecco-jcc/jjac115. J Crohns Colitis. 2023. PMID: 36005814 Free article. No abstract available.
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
Moens A, van der Woude CJ, Julsgaard M, Humblet E, Sheridan J, Baumgart DC, Gilletta De Saint-Joseph C, Nancey S, Rahier JF, Bossuyt P, Cremer A, Dewit S, Eriksson C, Hoentjen F, Krause T, Louis E, Macken E, Milenkovic Z, Nijs J, Posen A, Van Hootegem A, Van Moerkercke W, Vermeire S, Bar-Gil Shitrit A, Ferrante M. Moens A, et al. Among authors: ferrante m. Aliment Pharmacol Ther. 2020 Jan;51(1):129-138. doi: 10.1111/apt.15539. Epub 2019 Nov 6. Aliment Pharmacol Ther. 2020. PMID: 31692017 Free article.
Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies.
Fierens L, Liefferinckx C, Hoefkens E, Lobatòn T, Dreesen E, Sabino J, Ferrante M; IBD Research and Development (BIRD) group. Fierens L, et al. Among authors: ferrante m. J Crohns Colitis. 2022 Aug 4;16(7):1059-1069. doi: 10.1093/ecco-jcc/jjac009. J Crohns Colitis. 2022. PMID: 35078228
Safety and tolerability of spesolimab in patients with ulcerative colitis.
Ferrante M, Irving PM, Selinger CP, D'Haens G, Kuehbacher T, Seidler U, Gropper S, Haeufel T, Forgia S, Danese S, Klaus J, Feagan BG for the spesolimab in UC phase II clinical trial investigators. Ferrante M, et al. Expert Opin Drug Saf. 2023 Feb;22(2):141-152. doi: 10.1080/14740338.2022.2103536. Epub 2022 Jul 31. Expert Opin Drug Saf. 2023. PMID: 35861588 Clinical Trial.
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysis.
Rivière P, Pekow J, Hammoudi N, Wils P, De Cruz P, Wang CP, Mañosa M, Ollech J, Allez M, Nachury M, Kamm MA, Ahanori M, Ferrante M, Buisson A, Singh S, Laharie D, Diouf M, Fumery M. Rivière P, et al. Among authors: ferrante m. J Crohns Colitis. 2023 Mar 18;17(2):269-276. doi: 10.1093/ecco-jcc/jjac137. J Crohns Colitis. 2023. PMID: 36124813 Free PMC article.
What are the Unmet Needs and Most Relevant Treatment Outcomes According to Patients with Inflammatory Bowel Disease? A Qualitative Patient Preference Study.
Schoefs E, Vermeire S, Ferrante M, Sabino J, Lambrechts T, Avedano L, Haaf I, De Rocchis MS, Broggi A, Sajak-Szczerba M, Saldaña R, Janssens R, Huys I. Schoefs E, et al. Among authors: ferrante m. J Crohns Colitis. 2023 Apr 3;17(3):379-388. doi: 10.1093/ecco-jcc/jjac145. J Crohns Colitis. 2023. PMID: 36165579 Free PMC article. Review.
983 results